Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Medpace Clinical Research India Private Limited, is an unlisted private company incorporated on 07 March, 2007. It is classified as a private limited company and is located in Thane, Maharashtra. It's authorized share capital is INR 5.00 lac and the total paid-up capital is INR 1.00 lac.
Medpace Clinical Research India's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2021. It's EBITDA has increased by 18.28% over the previous year. At the same time, it's book networth has increased by 59.5%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Preeti Kabra | 03272393 | 2 years |
Director | Samir Shankar Dalvi | 07768456 | 2 years |
Director | Jesse Jacob Geiger | 08936155 | 5 years |
Director | Stephen Paul Ewald | 08936156 | 5 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
TATVA TECHNO VENTURES LLP |
Active
|
1.0 L | 1 | Gujarat |
PHYSIO-CONTROL INDIA SALES PRIVATE LIMITED |
Amalgamated
|
5.0 L | 1 | Delhi |
QAD INDIA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
CYGILANT (INDIA) RESEARCH AND DEVELOPMENT PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
ATHLETIC GREENS INDIA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
SHORTSTV NETWORKS INDIA PRIVATE LIMITED |
Active
|
1,000.0 | 1 | Maharashtra |
KNOTEL OFFICE SERVICES INDIA PRIVATE LIMITED |
Active
|
3.8 Cr | 1 | Delhi |
GENASCIS INDIA PRIVATE LIMITED |
Active
|
27.4 L | 1 | Chandigarh |
EIQNETWORKS (INDIA) RESEARCH AND DEVELOPMENT PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
GIIS K12 EDUCATION PRIVATE LIMITED |
Active
|
30.4 Cr | 1 | Maharashtra |
PRODIGY DEVELOPMENT INSTITUTION |
Active
|
25.5 Cr | 1 | Delhi |
Read more
The incorporation date of MEDPACE CLINICAL RESEARCH INDIA PRIVATE LIMITED is 07 March, 2007
The authorized share capital of MEDPACE CLINICAL RESEARCH INDIA PRIVATE LIMITED is INR ₹ 5.0 L.
The paid-up capital of MEDPACE CLINICAL RESEARCH INDIA PRIVATE LIMITED is INR ₹ 1.0 L.
The registered address of MEDPACE CLINICAL RESEARCH INDIA PRIVATE LIMITED is UNIT NO. 1203, 12TH FLOOR, BUILDING Q2, AURUM Q PARK, TTC IN DUSTRIAL AREA, THANE-BELAPUR ROAD, GHAN Thane Thane Maharashtra - 400710
The CIN number of MEDPACE CLINICAL RESEARCH INDIA PRIVATE LIMITED is U24232MH2007PTC338993.